Erenumab For Treatment of Hemicrania Continua

  • STATUS
    Recruiting
  • days left to enroll
    2
  • participants needed
    20
  • sponsor
    Mayo Clinic
Updated on 29 September 2021

Summary

This research is being conducting to learn if the study drug erenumab is successful in treating hemicrania continua. The study is also evaluating the safety and tolerability of erenumab in individuals being treated for hemicrania continua.

Details
Condition Hemicrania Continua
Treatment Erenumab
Clinical Study IdentifierNCT04303845
SponsorMayo Clinic
Last Modified on29 September 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Adults over the age of 18-66
At least a 12 month history of hemicrania continua (unremitting subtype) according to International Classification of Headache Disorders, 3rd Edition (ICHD-3)1
Previous or current complete response to indomethacin
Stable preventive treatment for at least 2 months and no anticipated need to adjust/add current headache prevention treatment

Exclusion Criteria

Nonresponse to a therapeutic dose of indomethacin for hemicrania continua when used for at least 1 week
Pregnant or lactating subjects
Use of barbiturate or opioid >6 days per month; history of chronic migraine
History of previous trigeminal-autonomic cephalalgia
History within previous 2 months of interventional procedure for headache (occipital or other extracranial nerve block, sphenopalatine ganglion block, cervical facet block, facet rhizotomy)
History of cranial nerve/rhizolysis
Botulinumtoxin injection with previous 4 months
Parenteral infusion of or oral corticosteroid use for more than 3 days within 4 weeks prior to screening phase
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note